Telomir Pharmaceuticals announced the appointment of Dr. Itzchak Angel as Chief Scientific Advisor. Dr. Angel, in collaboration with Telomir’s senior management, will look to expedite the pre-clinical and clinical path of Telomir’s lead product candidate, Telomir-1, a novel small molecule designed to lengthen the DNA’s protective telomere caps, which are crucial in the aging process. Dr. Angel was previously the Head of Pharmacology at Synthelabo.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TELO: